We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+6.42%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$35.6M
(+21%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-17.19%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
227
New
51
Increased
39
Reduced
41
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.06M |
| 2 |
Digital Turbine
APPS
|
+$1.87M |
| 3 |
Merck
MRK
|
+$1.39M |
| 4 |
Pfizer
PFE
|
+$1.11M |
| 5 |
Broadwind
BWEN
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DZSI
DZS Inc. Common Stock
DZSI
|
+$3.66M |
| 2 |
Aspen Aerogels
ASPN
|
+$2.95M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$2.56M |
| 4 |
Evolus
EOLS
|
+$1.72M |
| 5 |
indie Semiconductor
INDI
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.52% |
| 2 | Healthcare | 17.49% |
| 3 | Financials | 5.11% |
| 4 | Real Estate | 2.52% |
| 5 | Industrials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ideal Power
IPWR
$63.6M
| $550K | 0.27% |
52,588
| – | – |
|
52
Coya Therapeutics
COYA
$104M
| $543K | 0.26% |
137,758
| – | – |
|
|
YMAB
53
DELISTED
Y-mAbs Therapeutics
YMAB
| $523K | 0.26% |
+104,487
| New | +$427K |
|
54
Franklin Wireless
FKWL
$27.1M
| $492K | 0.24% |
98,826
| – | – |
|
55
Cellectar Biosciences
CLRB
$21.3M
| $485K | 0.24% |
11,220
| – | – |
|
|
NTST
56
NETSTREIT Corp
NTST
$2.08B
| $463K | 0.23% |
25,302
-372
| -1% | -$7.18K |
|
|
CTO
57
CTO Realty Growth
CTO
$827M
| $454K | 0.22% |
26,302
+600
| +2% | +$10.9K |
|
58
Abeona Therapeutics
ABEO
$364M
| $453K | 0.22% |
160,511
| – | – |
|
59
NVE Corp
NVEC
$595M
| $445K | 0.22% |
5,358
| – | – |
|
60
PTC Therapeutics
PTCT
$5.68B
| $434K | 0.21% |
+8,956
| New | +$409K |
|
|
DM
61
DELISTED
Desktop Metal, Inc.
DM
| $424K | 0.21% |
+18,450
| New | +$348K |
|
62
Nerdy
NRDY
$108M
| $411K | 0.2% |
+98,400
| New | +$301K |
|
63
Wolfspeed
WOLF
$1.27B
| $397K | 0.19% |
6,111
+2,325
| +61% | +$170K |
|
|
DFSC
64
DEFSEC Technologies
DFSC
$3.57M
| $395K | 0.19% |
702
| – | – |
|
65
NovoCure
NVCR
$1.78B
| $385K | 0.19% |
+6,400
| New | +$511K |
|
66
Fennec Pharmaceuticals
FENC
$333M
| $378K | 0.18% |
+45,438
| New | +$421K |
|
67
Aprea Therapeutics
APRE
$7.4M
| $378K | 0.18% |
+84,869
| New | +$627K |
|
68
Apyx Medical
APYX
$176M
| $374K | 0.18% |
+129,771
| New | +$379K |
|
|
RVLP
69
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $368K | 0.18% |
322,829
-133,131
| -29% | -$160K |
|
70
VICI Properties
VICI
$29.2B
| $367K | 0.18% |
11,257
-20,051
| -64% | -$663K |
|
|
LSI
71
DELISTED
Life Storage, Inc.
LSI
| $344K | 0.17% |
+2,625
| New | +$304K |
|
72
Sun Communities
SUI
$15.1B
| $336K | 0.16% |
+2,384
| New | +$348K |
|
73
Tyler Technologies
TYL
$12.5B
| $321K | 0.16% |
904
-287
| -24% | -$93.4K |
|
74
BioMarin Pharmaceuticals
BMRN
$11.6B
| $315K | 0.15% |
+3,239
| New | +$336K |
|
75
Kite Realty
KRG
$5.69B
| $310K | 0.15% |
14,800
| – | – |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Worth Venture Partners held 227 positions worth $205M, up 21% from $169M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Worth Venture Partners withdrew a net $35.2M in Q1 2023, closing 39 positions and reducing 41 holdings. Its most notable exit was Aspen Aerogels, an estimated $2.95M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Marinus Pharmaceuticals, Inc worth $2.27M.
- Worth Venture Partners's largest Q1 2023 buy was Marinus Pharmaceuticals, Inc: 328,735 shares worth $2.27M.
- Worth Venture Partners added most to Digital Turbine in Q1 2023, an estimated $1.87M increase.
- Worth Venture Partners's biggest Q1 2023 reduction was DZS Inc. Common Stock, cutting an estimated $3.66M.
- Worth Venture Partners fully exited Aspen Aerogels in Q1 2023, selling an estimated $2.95M.
- Worth Venture Partners's ten largest holdings make up 39% of its $205M portfolio in Q1 2023.
- Worth Venture Partners opened 51 new positions and closed 39 in Q1 2023.
- Worth Venture Partners's portfolio value rose 21% quarter-over-quarter to $205M.
Based on Worth Venture Partners's 13F filing for Q1 2023, filed 15 May 2023.